Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Ri-Ning Tang"'
Publikováno v:
Kidney Diseases, Pp 1-7 (2024)
Introduction: Roxadustat, the first-in-class drug for the treatment of renal anemia, has demonstrated efficacy in renal anemia with microinflammation. Additional data are needed regarding the efficacy of roxadustat on renal anemia with systemic macro
Externí odkaz:
https://doaj.org/article/3f8c81ff1608446e8f6344cddb7a01f8
Autor:
Yong-Qi Li, Min Wu, Yu-Jia Wang, Yu-Xia Zhang, Jing Lu, Yi-Nan Zhao, Bo-Fan Ji, Zhi-Qing Chen, Ri-Ning Tang, Bi-Cheng Liu
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2024)
Objectives: This study aimed to describe the effects of low-dose (prednisolone acetate 2.5–7.5 mg/day) glucocorticoids (GCs) maintenance therapy in patients with primary nephrotic syndrome (NS) suffering from coronavirus disease 2019 (COVID-19).Met
Externí odkaz:
https://doaj.org/article/d4ab5c1916d4421ab4b3463eee15f7f2
Autor:
Ye Feng, Xin Zhong, Hai-Feng Ni, Cui Wang, Tao-Tao Tang, Li-Ting Wang, Kai-Yun Song, Ri-Ning Tang, Hong Liu, Bi-Cheng Liu, Lin-Li Lv
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background Diabetic nephropathy (DN) is a leading cause of renal failure, whereas the effective and early diagnostic biomarkers are still lacking. Methods Fourteen cytokines and chemokines mRNA were detected in urinary extracellular vesicles
Externí odkaz:
https://doaj.org/article/e27aa031852b4dc9a60e12388fffb176
Autor:
Li‐ting Wang, Yu‐jia Wang, Yu‐xia Zhang, Si‐jie Chen, Zi‐Xiao Liu, Jing‐yuan Cao, Wei‐jie Ni, Tao‐tao Tang, Ri‐ning Tang, Xiao‐liang Zhang, Bi‐cheng Liu
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 5, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/01502f3a3606430ebdef9fca86ca577f
Autor:
Bin Wang, Qing Yin, Yu-Chen Han, Min Wu, Zuo-Lin Li, Yan Tu, Le-ting Zhou, Qing Wei, Hong Liu, Ri-Ning Tang, Jing-Yuan Cao, Lin-Li Lv, Bi-Cheng Liu
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 912-925 (2020)
Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are orally active first-in-class new generation drugs for renal anemia. This extensive meta-analysis of randomized controlled trials (RCTs) was designed to provide clear information on
Externí odkaz:
https://doaj.org/article/cfe722a3ee6a4ebc8b7cf6d8db4e421f
Autor:
Le-Ting Zhou, Shen Qiu, Lin-Li Lv, Zuo-Lin Li, Hong Liu, Ri-Ning Tang, Kun-Ling Ma, Bi-Cheng Liu
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 2, Pp 568-581 (2018)
Background/Aims: Chronic kidney disease (CKD) is a worldwide public health problem. Regardless of the underlying primary disease, CKD tends to progress to end-stage kidney disease, resulting in unsatisfactory and costly treatment. Its common pathogen
Externí odkaz:
https://doaj.org/article/7189836e388e42d0a38c9e647d3fc8af
Publikováno v:
Chinese Medical Journal, Vol 128, Iss 9, Pp 1268-1271 (2015)
Externí odkaz:
https://doaj.org/article/05755fc567bb488cbe54a1b292d42549
Autor:
Yu-Chen Han, Han-Ming Huang, Ling Sun, Chao-Ming Tan, Min Gao, Hong Liu, Ri-Ning Tang, Yan-Li Wang, Bei Wang, Kun-Ling Ma, Bi-Cheng Liu
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149038 (2016)
The growing burden of end-stage renal disease (ESRD) has been a great challenge to the health care system of China. However, the exact epidemiological data for ESRD in China remain unclear. We aimed to investigate the epidemiology of ESRD treated by
Externí odkaz:
https://doaj.org/article/bb37c7ccad5a46568d389cad9a1b8107
Autor:
Jun-Feng Chen, Hong Liu, Hai-Feng Ni, Lin-Li Lv, Ming-Hui Zhang, Ai-Hua Zhang, Ri-Ning Tang, Ping-Sheng Chen, Bi-Cheng Liu
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83593 (2013)
Dysfunctional mitochondria participate in the progression of chronic kidney disease (CKD). Pirfenidone is a newly identified anti-fibrotic drug. However, its mechanism remains unclear. Mitochondrial dysfunction is an early event that occurs prior to
Externí odkaz:
https://doaj.org/article/75cdb78dd4e545d79ac8f03090792978
Publikováno v:
Seminars in Dialysis. 35:40-49
BACKGROUND Dialysis unit blood pressure (BP) pattern showed superiority in prognostic evaluation and interdialytic BP burden assessment. However previous studies mainly focused on the recurrent BP pattern within a session (intradialytic BP change or